Produkty 25614-03-3

CAS 25614-03-3 to numer rejestracyjny substancji Bromocriptine. Oferty producentów: Chemat Brand, MedChemExpress. Dostępne opakowania: on request, Get quote.

Bromocriptine
Chemat Brand, MedChemExpress
  • opakowanie: on request, Get quote
  • Warianty: 2
Zobacz produkt

(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide (CAS 25614-03-3) to związek chemiczny o wzorze sumarycznym C32H40BrN5O5 i masie molowej 654.6 g/mol. Nazwa systematyczna IUPAC: (6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide. InChIKey: OZVBMTJYIDMWIL-AYFBDAFISA-N.

Dane identyfikacyjne
Wzór sumarycznyC32H40BrN5O5
Masa molowa654.6 g/mol
Nazwa IUPAC(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
InChIKeyOZVBMTJYIDMWIL-AYFBDAFISA-N
SMILESCC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: bromocriptine, Bromoergocryptine, Bromocriptin, Bromoergocriptine, Bromergocryptine, 2-Bromo-alpha-ergocryptine, Bromocriptina, 2-Bromo-alpha-ergokryptin, 2-Bromo-alpha-ergokryptine, Bromocriptinum
Powiązane formy tego związku
(6aR,9S)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide C32H40BrN5O5
(6aR,9R)-5-bromo-N-[(1S,2S,4S,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide C32H40BrN5O5
(6aR,9R)-5-bromo-N-[(1S,2S,4R,7R)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide C32H40BrN5O5